TR200301248A2 - Pharmaceutical Compositions with Antibiotic Activity. - Google Patents

Pharmaceutical Compositions with Antibiotic Activity.

Info

Publication number
TR200301248A2
TR200301248A2 TR2003/01248A TR200301248A TR200301248A2 TR 200301248 A2 TR200301248 A2 TR 200301248A2 TR 2003/01248 A TR2003/01248 A TR 2003/01248A TR 200301248 A TR200301248 A TR 200301248A TR 200301248 A2 TR200301248 A2 TR 200301248A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
antibiotic activity
antibiotic
thromethamol
phosphomycin
Prior art date
Application number
TR2003/01248A
Other languages
Turkish (tr)
Inventor
Rampold� Luca
Pirrone Luca
Faccin Sarah
Grassano Alessandro
Gurr�Er� G�Ovann�
Original Assignee
Zambon Group S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27638551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200301248(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zambon Group S.P.A filed Critical Zambon Group S.P.A
Publication of TR200301248A2 publication Critical patent/TR200301248A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Antibiyotik Fosfomisin Trometamolü stabilize edici maddesi olarak bazi tuzlarin ve aminoasitlerin kulanilmasi ve bunlari ihtiva eden farmasotik kompozisyonlar tarif edilmektedir.Antibiotic Phosphomycin The use of certain salts and amino acids as a stabilizing agent for thromethamol and pharmaceutical compositions containing them are described.

TR2003/01248A 2002-08-01 2003-08-01 Pharmaceutical Compositions with Antibiotic Activity. TR200301248A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001725A ITMI20021725A1 (en) 2002-08-01 2002-08-01 PHARMACEUTICAL COMPOSITIONS WITH ANTIBIOTIC ACTIVITY.

Publications (1)

Publication Number Publication Date
TR200301248A2 true TR200301248A2 (en) 2004-02-23

Family

ID=27638551

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01248A TR200301248A2 (en) 2002-08-01 2003-08-01 Pharmaceutical Compositions with Antibiotic Activity.

Country Status (29)

Country Link
US (1) US7303755B2 (en)
JP (1) JP4395338B2 (en)
KR (1) KR100966977B1 (en)
AT (1) AT500521B1 (en)
BE (1) BE1017903A3 (en)
BR (1) BRPI0302496C1 (en)
CA (1) CA2434927C (en)
CH (1) CH696718A5 (en)
CO (1) CO5480297A1 (en)
CZ (1) CZ305023B6 (en)
DE (1) DE10334820B4 (en)
DK (1) DK178348B1 (en)
ES (1) ES2224869B1 (en)
FI (1) FI120080B (en)
FR (1) FR2852845B1 (en)
GR (1) GR20030100300A (en)
HR (1) HRP20030618B1 (en)
HU (1) HU230575B1 (en)
IL (1) IL156615A (en)
IT (1) ITMI20021725A1 (en)
NL (1) NL1023790C2 (en)
PL (1) PL209644B1 (en)
PT (1) PT102995B (en)
RU (1) RU2333000C2 (en)
SE (1) SE527466C2 (en)
SI (1) SI21259B (en)
SK (1) SK287201B6 (en)
TR (1) TR200301248A2 (en)
ZA (1) ZA200305040B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE740685C (en) * 1941-04-11 1943-10-26 Voigt & Haeffner Ag Four-stroke control switch for parallel, individual and series connection of heating resistors
ES2244333B1 (en) * 2004-05-18 2006-08-01 Simbec Iberica, Sl ORAL PHARMACEUTICAL PREPARATION OF STABLE PHOSPHOMYCIN AND SUITABLE FOR DIABETICS.
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (en) 2006-05-04 2008-04-25 Boehringer Ingelheim Int USES OF DPP IV INHIBITORS
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BR112012007234A2 (en) 2009-10-02 2016-04-05 Boehringer Ingelheim Int pharmaceutical combination comprising dpp-4 inhibitor and metformin, as well as their use and preparation process
EA021876B1 (en) * 2010-09-20 2015-09-30 ЛИМОНОВ, Виктор Львович Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
ES2385158B1 (en) * 2010-12-24 2013-05-28 Arafarma Group, S.A. PHARMACEUTICAL PHOSPHOMYCIN COMPOSITION
CN102579466A (en) * 2011-01-10 2012-07-18 王乐 Composition of fosfomycin or fosfomycin arginine salt and arginine
US8604078B2 (en) * 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
ITTO20130839A1 (en) * 2013-10-16 2015-04-17 C & G Farmaceutici S R L COMPOSITION BASED ON PHOSPHOMYCIN TROMETAMOL
DE102014218913A1 (en) * 2014-09-19 2016-03-24 Heraeus Medical Gmbh A process for producing an antibiotic polymethyl methacrylate bone cement powder and an antibiotic polymethyl methacrylate bone cement powder
CN104546689B (en) * 2015-01-07 2019-01-25 同方药业集团有限公司 A kind of pharmaceutical composition containing metronidazole
US20180360855A1 (en) 2015-12-25 2018-12-20 Yusuf Toktamis ÖGÜN The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
KR102391564B1 (en) 2016-06-10 2022-04-29 베링거 인겔하임 인터내셔날 게엠베하 Combination of Linagliptin and Metformin
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852434A (en) 1970-09-11 1974-12-03 Merck & Co Inc Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
IT1161974B (en) 1978-02-02 1987-03-18 Italchemi Spa CIS.I 2 EPOXYPROPYLPHOSPHONIC ACID DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1112282B (en) 1978-07-19 1986-01-13 Zambon Spa Bis- (2-AMMONIUM-2-hydroxymethyl-1,3-propanediol) (2R-CIS) - (3-METILOSSIRANIL) phosphonate
IT1124610B (en) 1979-10-18 1986-05-07 Zambo Spa MONO (2-AMMONIUM-2-HYDROXYMETHYL-1,3-PROPANDIOL) (2R-CIS) - (O-METHYLOXYRANYL) PHOSPHONATE
JPS59104326A (en) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd Stable oral preparation of macrolide antibiotic substance, and method for stabilizing the same
CH660305A5 (en) * 1984-10-05 1987-04-15 Schering Spa WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS BASED ON SALTS OF (-)CIS-1,2-EPOXYPROPYLPHOSPHONIC ACID WITH AMINO ACIDS.
US5182274A (en) * 1988-09-26 1993-01-26 Teijin Limited Stabilized aqueous preparation of active form of vitamin d3
IT1231013B (en) 1989-07-27 1991-11-08 Zambon Spa MONO (2 AMMONIUM 2 HYDROXYMETHYL 1,3 PROPANDIOL) (2R, CIS) 1,2 EPOSSIPROPIL PHOSPHONATE HAVING IMPROVED STABILITY AND WORKABILITY CHARACTERISTICS.
US5191094A (en) 1989-07-27 1993-03-02 Zambon Group S.P.A. Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing
IT1244543B (en) 1991-02-01 1994-07-15 La Fa Re Srl TOPICAL USE OF PHOSPHOMYCIN AND ITS SALTS IN THE TREATMENT OF VAGINAL AND / OR URETHRAL INFECTIONS
FR2690340B1 (en) 1992-04-24 1995-02-24 Scr Newmed New process for stabilizing liquid pharmaceutical preparations and the pharmaceutical compositions thus stabilized resulting therefrom.
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4327063A1 (en) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenone particles with modified physicochemical properties
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH09183730A (en) * 1995-05-10 1997-07-15 Meiji Seika Kaisha Ltd Medicine containing enantiomer of fosfomycin
DE19712565A1 (en) 1997-03-25 1998-10-01 Thomas W Dr Stief Composition containing singlet oxygen or photon generator
US6413946B1 (en) * 1997-10-03 2002-07-02 Meiji Seika Kaisha, Ltd. Composition for treatment of diabetes and treatment of diabetes
RU2133122C1 (en) * 1998-10-14 1999-07-20 Научно-исследовательский институт биомедицинской химии РАМН Composition exhibiting property for biological membrane repairing
KR20080056308A (en) * 2000-06-21 2008-06-20 큐비스트 파마슈티컬즈 인코포레이티드 Compositions and methods for improving oral absorption of antimicrobial agents
US6699505B2 (en) * 2000-10-17 2004-03-02 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by compexing with cyclodextrins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
CH696718A5 (en) 2007-10-31
AT500521B1 (en) 2007-11-15
CA2434927C (en) 2011-10-18
HUP0302441A2 (en) 2005-07-28
GR20030100300A (en) 2004-04-22
ES2224869B1 (en) 2007-07-01
HRP20030618A2 (en) 2004-04-30
SK287201B6 (en) 2010-03-08
DK178348B1 (en) 2016-01-04
KR20040012569A (en) 2004-02-11
CA2434927A1 (en) 2004-02-01
PL361518A1 (en) 2004-02-09
ES2224869A1 (en) 2005-03-01
SE527466C2 (en) 2006-03-14
SI21259B (en) 2012-12-31
DK200301097A (en) 2004-02-02
FI20031078A7 (en) 2004-02-02
FI120080B (en) 2009-06-30
PT102995A (en) 2004-02-27
SE0302129D0 (en) 2003-07-25
PT102995B (en) 2004-07-30
JP2004067682A (en) 2004-03-04
BR0302496A (en) 2004-08-24
SE0302129L (en) 2004-02-02
SK9762003A3 (en) 2004-02-03
HRP20030618B1 (en) 2011-10-31
BRPI0302496B8 (en) 2016-09-13
US7303755B2 (en) 2007-12-04
ZA200305040B (en) 2004-05-11
DE10334820B4 (en) 2020-02-06
NL1023790C2 (en) 2004-03-10
JP4395338B2 (en) 2010-01-06
HU230575B1 (en) 2017-02-28
KR100966977B1 (en) 2010-06-30
US20040022866A1 (en) 2004-02-05
RU2333000C2 (en) 2008-09-10
CZ20032096A3 (en) 2004-03-17
CO5480297A1 (en) 2005-01-28
IL156615A0 (en) 2004-01-04
BE1017903A3 (en) 2009-11-03
ITMI20021725A1 (en) 2002-10-31
FR2852845B1 (en) 2006-01-06
AT500521A1 (en) 2006-01-15
IL156615A (en) 2008-11-26
CZ305023B6 (en) 2015-04-01
PL209644B1 (en) 2011-09-30
FR2852845A1 (en) 2004-10-01
BRPI0302496C1 (en) 2021-05-25
DE10334820A1 (en) 2004-03-11
FI20031078A0 (en) 2003-07-16
SI21259A (en) 2004-02-29
BRPI0302496B1 (en) 2015-07-28
RU2003124299A (en) 2005-01-20
HU0302441D0 (en) 2003-09-29
NL1023790A1 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
TR200301248A2 (en) Pharmaceutical Compositions with Antibiotic Activity.
ECSP20027480A (en) INDOLIL ALKYL AMINO DERIVATIVES SUBSTITUTED AS NEW INHIBITORS OF HISTONE DESACETILASE
BRPI0317696B8 (en) whitening composition
DE60328010D1 (en) HETEROCYCLIC COMPOUNDS
EA200401204A1 (en) SULPHINYL DERIVATIVES AS NEW HISTON-DEACETYLASE INHIBITORS
TR200002480T2 (en) Guanidine derivatives for the treatment of izazemi
EA200401202A1 (en) SULPHINYL DERIVATIVES AS NEW HISTON-DEACETYLASE INHIBITORS
NO20005237L (en) Heterocyclic substituted amides used as calpain inhibitors
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
GEP20084367B (en) Diazepinoindole derivatives as kinase inhibitors
EA200800240A1 (en) TIAZOLE DERIVATIVES AS AMPK ACTIVATOR
NZ533994A (en) Amino alcohol derivative or phosphonic acid derivative and medicinal compostion containing these
EA200800302A1 (en) APPLICATION OF DERIVATIVES AND ANALOGUES OF THIAZOLE IN TREATMENT OF CANCER
BRPI0410727A (en) compound, pharmaceutical composition, and use of a compound
DE60333746D1 (en) thienyl compounds
UY27619A1 (en) ESTERS HYDROXAMATE OF ACID N- (SUBSTITUTED 4-PHENYL) - ANTRANÍLICO
BRPI0413151A (en) amino propanol derivatives
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
RS51694B (en) Novel perindopril salt and pharmaceutical compositions containing same
BRPI0412320A (en) use of a rheology modifying agent, and coating compositions
UY27618A1 (en) ESTERS HYDROXAMATE ACID N- (4-PHENYL-SUBSTITUTED) -ANTRANILIC
SE0302546D0 (en) New compounds
BRPI0410861A (en) methods and compositions for the production of amino acids
MXPA04009476A (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors.
EA200700901A1 (en) DERIVATIVES 2-AMIDO-4-PHENYL THIAZOLE, THEIR OBTAINING AND USE IN THERAPY